surfactanttoediening
Surfactant administration refers to the medical practice of delivering synthetic or natural surfactant into the lungs of premature infants or adults with severe respiratory distress. Surfactant is a complex mixture of lipids and proteins that reduces surface tension within the alveoli, preventing their collapse and improving lung compliance. This treatment is primarily used in neonatal intensive care units (NICUs) to manage respiratory distress syndrome (RDS), a condition commonly affecting premature infants due to insufficient surfactant production.
The procedure typically involves the use of exogenous surfactant, often administered through an endotracheal tube inserted
Indications for surfactant administration extend beyond neonatal RDS to include meconium aspiration syndrome, pneumonia, and acute
Surfactant therapy has significantly improved neonatal survival rates and reduced the need for mechanical ventilation in